Dr. Ryan Clark, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 |
Dr. Christopher F. Heck, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 400 East Third Street, Essentia Health Duluth Clinic, Duluth, MN 55805 Phone: 218-786-3900 Fax: 218-722-1827 |
Frazier Eales, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 |
Dr. David Allen Arzouman, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 400 East 3rd Street, Smdc Medical Center-duluth Clinic, Duluth, MN 55805 Phone: 218-786-3900 Fax: 715-552-8091 |
News Archive
Platelets, which allow blood to clot, are at the heart of numerous cardiovascular problems, including heart attacks and stroke. New research has uncovered a key platelet protein that could offer a new angle for developing drugs to prevent thrombosis, or dangerous blood clots, in patients who are at high risk such as those with atherosclerosis or a history of heart problems.
Experts have warned that drug-resistant malaria could spread from Southeast Asia to Africa within months, putting millions of children's lives at risk. Nicholas White, professor of tropical medicine at Mahidol University in Bangkok warned that a malaria strain resistant to the drug artemisinin that first emerged along the Thai-Cambodian border in 2007.
The addition of docetaxel (Taxotere) to an initial chemotherapy regimen for inoperable head and neck cancers reduced mortality by nearly 30 percent over three years following treatment compared to the standard two-drug combination.
IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced another step in the implementation of its strategy to expand its product line for treating patients with peripheral vascular disease with the addition of two longer stents to its SUPERA product line.
Results of a statewide pain survey revealed that chronic pain is widespread among Pennsylvania women but often left untreated.
› Verified 7 days ago